Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
An automatic rebalancing portfolio automatically adjusts holdings to preserve the intended allocation across assets.
16,083 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A new $6 billion prize pool is attracting tech giants as they vie for breakthroughs in AI-safe security, cloud resili...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...
Dividend income can be a reliable part of a retirement plan. This guide shows the math behind earning $12,000 annuall...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...
Stocks hover near record highs as earnings show resilience, but analysts warn that the gap between prices and profits...
A playful moment between a football icon and his wife went viral, but the real lesson is how public moments shape mon...
Official Q2 data show china’s economy slows weakest in over three years, with 4.3% annualized growth as domestic dema...
The Trump administration presses more to accelerate domestic memory fabrication, aiming to reduce reliance on oversea...
SpaceX stock stumbled since its IPO has sparked questions about what comes next. By charting historical IPO patterns ...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...
A market-minded investor argues the reason keep buying amazon hinges on a massive, pre-contracted AWS backlog and a r...